Recently, for a distinguished audience of professionals working in the biopharmaceutical and life sciences industries, S Phase was invited to present its world-class BI solutions that impact marketing, compliance, sales operations, and analytics. Blake Walter, Associate Director of Analytics, introduced attendees to S Phase's proprietary cloud-based SaaS analytics platform.
"Currently, data sets from biopharmaceutical companies and other sources reside separately in different locations within the ecosystem," explained Blake Walter, "and S Phase's goal is to collect and integrate these disparate data sources, analyze trends, glean insights, and then provide those insights back to our biopharmaceutical clients." Giovanni Gomez, Director of Software Development, added that "the engine behind our business intelligence solutions follows standards-based practices to ensure data security. Our data warehouse allows us to provide blended, cleansed, and secure views of data and organize billions of data points into visualizations that are customized to the end user."
The BI engine is architected to optimize the strategic planning and assessments that are vital to medical communications initiatives (such as speaker programs) via intuitive real-time, on-demand analyticsa capability that S Phase calls Analytical Services to Optimize the Understanding of Data, or ASTOUND. Its adjacent product, the Monitoring Dashboard and Repository (or MDR), leverages sophisticated linking capabilities that enable real-time visibility into compliance documents as events occur. S Phase's ability to proactively identify trends and patterns allows biopharmaceutical clients to optimize the value of speaker program education and prevent compliance deviations.
Jeff Giampalmi, CEO of S Phase's parent company Conisus, described ASTOUND and MDR as "first-in-class and best-in-class digital solutions providing marketing, compliance, and sales operations with high-quality, longitudinal data. These capabilities," he continued, "are unparalleled in the biopharmaceutical industry and enable end users to monitor events and make adjustments in real time."
Deborah Prince, President of S Phase, is confident that BI innovation gives S Phase a key advantage in an otherwise highly competitive marketplace. "Our innovation at S Phase allows us to bring an array of additional industry-leading BI services to the tableservices that enable biopharmaceutical companies to synthesize disparate data sources and solve the complex challenges faced by their U.S. and Global brand teams." Those services include the Automated Thought Leader Analytics System (ATLAS) that provides end users with on-demand thought leader management dashboards that have evolved well beyond the spreadsheet norm. Flexible and responsive, ATLAS dashboards enable clients to perceptualize pertinent healthcare provider and competitive data aggregated across client-supplied and publicly available sources.
S Phase introduced this software platform only within the last year and, already, half a dozen biopharmaceutical companies are using these digital solutions, and several more are expected to sign up before 2018.
About S Phase
Based in Atlanta, S Phase is a leading provider of strategic medical communications services to the biopharmaceutical industry. We are dedicated to improving the care of patients with serious or life-threatening conditions by delivering unparalleled medical education programs to healthcare professionals. Our goal is to provide best-in-class strategic services while demonstrating unrivaled service to healthcare professionals and clients, ensuring that all operations reflect the highest degree of integrity.